Clinical Trial to Evaluate Efficacy of Redifferentiation Therapy Using Alpha-lipoic Acid in Thyroid Cancer Patients With Decreased Radioactive Iodine Uptake
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Increment of radioactive iodine uptake
3months after alpha-lipoic acid treatment
No
South Korea: Korea Food and Drug Administration (KFDA)
AMC_THY_001
NCT01396733
April 2011
December 2013
Name | Location |
---|